Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: TELCON RF PHARMACEUTICAL. Inc.

Market Cap 24.67B 16.3M 14.06M 12.95M 12.16M 22.77M 1.54B 23.04M 153M 59.71M 754M 61.14M 59.84M 2.62B P/E Ratio 2024
-2.64x
P/E Ratio 2025 -3.84x
Enterprise Value 26.81B 17.72M 15.28M 14.07M 13.22M 24.74M 1.68B 25.04M 166M 64.9M 819M 66.46M 65.04M 2.84B EV / Sales 2024
3.07x
EV / Sales 2025 1.51x
Free-Float
86.58%
Yield 2024 *
-
Yield 2025 -
04-17 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 3 billion in funding from Nuon Co., Ltd. CI
04-16 KPM TECH Co., Ltd. announced that it has received KRW 7.9999997 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-06 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 3 billion in funding from Nuon Co., Ltd. CI
04-06 KPM TECH Co., Ltd. announced that it expects to receive KRW 7.999999854 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
25-05-23 Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won RE
25-04-21 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
25-04-20 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
25-03-17 TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt CI
24-12-22 ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
24-12-11 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 2.5 billion in funding CI
24-12-10 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 2.5 billion in funding CI
24-12-04 ABION Inc. completed the acquisition of 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc.. CI
24-12-04 ABION Inc. announced that it has received KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
1 day-0.28%
Current month-11.98%
1 month-34.19%
3 months-54.14%
6 months-63.86%
Current year-60.74%
1 month 325
Extreme 325
549
Current year 325
Extreme 325
1,150
1 year 325
Extreme 325
4,433.33
3 years 325
Extreme 325
4,433.33
5 years 325
Extreme 325
18,166.67
10 years 325
Extreme 325
64,833.33
Manager TitleAgeSince
Chief Executive Officer 56 2017-10-31
Director of Finance/CFO 50 2019-03-27
Corporate Officer/Principal 54 2022-03-29
Director TitleAgeSince
Director/Board Member 50 2019-03-27
Director/Board Member 49 2019-03-27
Director/Board Member 56 2017-10-31
Date Insider Type Main position Quantity % Market Cap.
25-08-19Fiscal yearCompany 1,111,280 4.8639%
25-08-19ConversionCompany 1,111,280 4.8639%
25-07-29FreeCompany 2,222,560 18.4828%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%0.00%-73.40%-90.83% 16.27M
-0.77%-1.21%+87.50%+135.81% 477B
+4.66%-0.89%+251.20%+222.07% 206B
+3.58%+9.61%+83.10%+300.02% 206B
+8.36%+5.51%+967.30%+1,245.43% 189B
-3.32%-4.17%+179.18%+222.24% 84.2B
+3.87%+10.84%+1,060.78%+1,596.33% 71.7B
-0.13%+0.34%+0.89%+47.94% 68.43B
+3.91%-5.08%+542.20%+944.42% 63.13B
+0.47%+0.68%+18.30%+123.53% 45.92B
Average +0.89%-1.24%+311.70%+474.70% 141.12B
Weighted average by Cap. +1.50%+1.12%+297.54%+432.02%

Financials

2024 2025
Net sales 37.87B 25.03M 21.58M 19.88M 18.67M 34.95M 2.37B 35.37M 235M 91.67M 1.16B 93.87M 91.86M 4.02B 43.16B 28.53M 24.6M 22.66M 21.28M 39.84M 2.7B 40.31M 268M 104M 1.32B 107M 105M 4.58B
Net income -26.32B -17.4M -15M -13.82M -12.98M -24.29M -1.65B -24.58M -163M -63.72M -804M -65.25M -63.85M -2.79B -11.46B -7.57M -6.53M -6.01M -5.65M -10.57M -717M -10.7M -71.13M -27.73M -350M -28.4M -27.79M -1.22B
Net Debt 45.65B 30.18M 26.02M 23.97M 22.51M 42.14M 2.86B 42.64M 283M 111M 1.4B 113M 111M 4.84B 2.14B 1.42M 1.22M 1.13M 1.06M 1.98M 134M 2M 13.31M 5.19M 65.52M 5.31M 5.2M 227M
Logo TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
Employees
126
  1. Stock Market
  2. Stocks
  3. A200230 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!